(Q39775863)

English

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

steatohepatitis

0 references

author name string

Kosuke Kaji

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Hitoshi Yoshiji

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Mitsuteru Kitade

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yasuhide Ikenaka

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ryuichi Noguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yusaku Shirai

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yosuke Aihara

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Tadashi Namisaki

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Junichi Yoshii

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Koji Yanase

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Tatsuhiro Tsujimoto

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Hideto Kawaratani

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Hiroshi Fukui

13

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

3 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

300

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

G1094-104

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Deferasirox: oral, once daily iron chelator--an expert opinion

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Angiogenesis in life, disease and medicine

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Steatohepatitis: a tale of two "hits"?

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00365.2010

21 January 2018

Identifiers

10.1152/AJPGI.00365.2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39775863&oldid=2090216139"